RLYB Insider Trading - Rallybio Corporation

已發行股份	5,289,675 shares
內部人士股份	3,917,620 shares
內部持股	74.06 %
所有內部人士	29

內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。

如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。

內部人士買入淨數（排名）

1 ( )

329 out of 10931

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。

內部人士買入佔流通股比例（排名）

23.376% ( )

10 out of 10786

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Rallybio Corporation內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。

See our leaderboard of most profitable insider traders.

內部人士	持股數量	分拆調整
5AM Opportunities I (GP), LLC 10% Owner - [10%]	1,406,098	309,871
5AM Opportunities I, L.P. 10% Owner - [10%]	2,478,969	309,871
5AM Partners V, LLC 10% Owner - [10%]	3,630,724	453,840
5AM Ventures V, L.P. 10% Owner - [10%]	1,406,098	453,840
ADAR1 Capital Management, LLC 10% Owner - [10%]	926,352	926,352
Helen M Boudreau Director - [D]	23,882	2,985
FMR LLC / Fidelity Management & Research 10% Owner - [10%]	211,798	211,798
Jeffrey M Fryer See Remarks - [O]	47,048	5,881
Ole Andreas Halvorsen 10% Owner - [10%]	4,194,777	524,347

內部人士	持股數量	分拆調整
Ronald Hunt Director - [D]	2,301,603	287,700
Robert Lorne Hopfner Director - [D]	2,267,411	283,426
Lucian Iancovici Director - [D]	0	0
Jonathan I Lieber Chief Financial Officer - [O]	4,115	4,115
Hui Liu	2,240
Martin Mackay Chief Executive Officer, Director - [D] [O]	282,609	35,326
Christine A Nash	2,240
Ott David C. 10% Owner - [10%]	4,194,777	524,347
Kush Parmar Director - [D]	3,630,724	453,840
Scott M Rocklage 10% Owner - [10%]	2,578,640	453,840

內部人士	持股數量	分拆調整
Steven Ryder Chief Medical Officer - [O]	192,370	24,046
Timothy M Shannon Director - [D]	2,409,712	301,214
Schwab Andrew J. 10% Owner - [10%]	2,784,626	453,840
Rose Sharon Shabet 10% Owner - [10%]	4,194,777	524,347
Paula Soteropoulos Director - [D]	23,882	2,985
Stephen Uden See Remarks - [O]	719,127	89,891
Viking Global Investors Lp 10% Owner - [10%]	4,194,777	524,347
Viking Global Opportunities GP LLC 10% Owner - [10%]	4,194,777	524,347
Viking Global Opportunities Illiquid Investments Sub-Master LP 10% Owner - [10%]	4,194,777	524,347
Viking Global Opportunities Portfolio GP LLC 10% Owner - [10%]	4,194,777	524,347

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分，我們分析了在 RLYB / Rallybio Corporation 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
2026-05-19	ADAR1 Capital Management, LLC	200	13.8000	200	13.8000	2,760	13	16.8700	614	22.25
2026-05-19	ADAR1 Capital Management, LLC	10,000	13.9822	10,000	13.9822	139,822
2026-05-18	ADAR1 Capital Management, LLC	6,009	13.9759	6,009	13.9759	83,981
2026-05-15	ADAR1 Capital Management, LLC	200	13.9500	200	13.9500	2,790
2026-05-15	ADAR1 Capital Management, LLC	100	13.8000	100	13.8000	1,380
2026-05-13	ADAR1 Capital Management, LLC	75,178	14.0000	75,178	14.0000	1,052,492
2026-05-13	ADAR1 Capital Management, LLC	4,081	13.7993	4,081	13.7993	56,315
2026-05-12	ADAR1 Capital Management, LLC	800	13.8288	800	13.8288	11,063
2026-05-11	ADAR1 Capital Management, LLC	19,900	14.0000	19,900	14.0000	278,600

經調整價格已按拆股調整。經調整股數已按拆股調整。

RLYB / Rallybio Corporation Insider Trades

追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分，我們分析了在 RLYB / Rallybio Corporation 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
2026-02-23	Lieber Jonathan I	789	5.0600	789	5.0600	3,992	0	5.5000	348	8.70
2023-03-07	5AM Partners V, LLC	100,000	8.2000	12,500	65.6000	820,000
2022-06-03	5AM Opportunities I, L.P.	50,329	12.5000	6,291	100.0000	629,112
2022-06-03	5AM Opportunities I, L.P.	99,671	12.5000	12,459	100.0000	1,245,888
2022-05-23	5AM Opportunities I, L.P.	66,447	13.0000	8,306	104.0000	863,811
2022-05-23	5AM Opportunities I, L.P.	33,553	13.0000	4,194	104.0000	436,189
2022-02-08	5AM Opportunities I, L.P.	139,539	13.0500	17,442	104.4000	1,820,984
2022-02-08	5AM Opportunities I, L.P.	70,461	13.0500	8,808	104.4000	919,516

經調整價格已按拆股調整。經調整股數已按拆股調整。

交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。

呈報日期	交易日期	表格	內部人士	證券代碼	證券種類	代碼	直接	行使價格	單位價格	股數變化	價值變化 (1K)	剩餘期權	剩餘股份
2026-05-20	2026-05-19	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.8000	200	3		926,352
2026-05-20	2026-05-19	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.9822	10,000	140		926,152
2026-05-20	2026-05-18	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.9759	6,009	84		916,152
2026-05-15	2026-05-15	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.9500	200	3		910,143
2026-05-15	2026-05-15	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.8000	100	1		909,943
2026-05-15	2026-05-13	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		14.0000	75,178	1,052		909,843
2026-05-15	2026-05-13	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.7993	4,081	56		834,665
2026-05-13	2026-05-12	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.8288	800	11		830,584
2026-05-13	2026-05-11	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		14.0000	19,900	279		829,784
2026-05-13	2026-05-11	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		14.0000	25,000	350		809,884
2026-05-13	2026-05-11	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.9984	5,100	71		784,884
2026-05-06	2026-05-05	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.9956	35,101	491		779,784
2026-05-06	2026-05-04	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.9705	116,904	1,633		744,683
2026-05-06	2026-05-04	4	ADAR1 Capital Management, LLC	RLYB	Common Stock	P - Purchase	I		13.8978	3,900	54		627,779
2026-05-06		3	ADAR1 Capital Management, LLC	RLYB	Common Stock		I						623,879
2026-03-10		3	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	RLYB	Common Stock		I						211,798
2026-02-23	2026-02-23	4	Lieber Jonathan I	RLYB	Common Stock	S - Sale	D		5.0600	-789	-4		4,115
2026-02-23	2026-02-18	4	Lieber Jonathan I	RLYB	Common Stock	A - Award	D			2,500			4,904
2023-03-16	2023-03-14	4	Lieber Jonathan I	RLYB	Common Stock	P - Purchase	D		5.2100	5,000	26		5,000
2023-03-09	2023-03-07	4	PARMAR KUSH By 5AM Ventures V, L.P.	RLYB	Common Stock	S - Sale	I		8.2000	-100,000	-820		2,378,969
2023-03-09	2023-03-07	4	5AM Partners V, LLC By 5AM Ventures V, L.P.	RLYB	Common Stock	S - Sale	I		8.2000	-100,000	-820		2,378,969
2022-06-07	2022-06-03	4	PARMAR KUSH By 5AM Opportunities I, L.P.	RLYB	Common Stock	S - Sale	I		12.5000	-50,329	-629		1,251,755
2022-06-07	2022-06-03	4	PARMAR KUSH By 5AM Ventures V, L.P.	RLYB	Common Stock	S - Sale	I		12.5000	-99,671	-1,246		2,478,969
2022-06-07	2022-06-03	4	5AM Opportunities I, L.P. By 5AM Ventures V, L.P.	RLYB	Common Stock	S - Sale	I		12.5000	-99,671	-1,246		2,478,969
2022-06-07	2022-06-03	4	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	RLYB	Common Stock	S - Sale	I		12.5000	-50,329	-629		1,251,755
2022-05-26	2022-05-24	4	Liu Hui	RLYB	Option (Right to Buy)	A - Award	D	12.75		2,240		2,240
2022-05-26	2022-05-24	4	HUNT RONALD	RLYB	Option (Right to Buy)	A - Award	D	12.75		13,440		13,440
2022-05-26	2022-05-24	4	Soteropoulos Paula	RLYB	Option (Right to Buy)	A - Award	D	12.75		13,440		13,440
2022-05-26	2022-05-24	4	Nash Christine A	RLYB	Option (Right to Buy)	A - Award	D	12.75		2,240		2,240
2022-05-26	2022-05-24	4	Hopfner Robert Lorne	RLYB	Option (Right to Buy)	A - Award	D	12.75		13,440		13,440
2022-05-26	2022-05-24	4	Boudreau Helen M	RLYB	Option (Right to Buy)	A - Award	D	12.75		13,440		13,440
2022-05-26	2022-05-24	4	PARMAR KUSH	RLYB	Option (Right to Buy)	A - Award	D	12.75		13,440		13,440
2022-05-25	2022-05-23	4	PARMAR KUSH By 5AM Opportunities I, L.P.	RLYB	Common Stock	S - Sale	I		13.0000	-33,553	-436		1,302,084
2022-05-25	2022-05-23	4	PARMAR KUSH By 5AM Ventures V, L.P.	RLYB	Common Stock	S - Sale	I		13.0000	-66,447	-864		2,578,640
2022-05-25	2022-05-23	4	5AM Opportunities I, L.P. By 5AM Ventures V, L.P.	RLYB	Common Stock	S - Sale	I		13.0000	-66,447	-864		2,578,640
2022-05-25	2022-05-23	4	5AM Opportunities I, L.P. By 5AM Opportunities I, L.P.	RLYB	Common Stock	S - Sale	I		13.0000	-33,553	-436		1,302,084
2022-04-06	2022-04-04	4	Nash Christine A	RLYB	Option (Right to Buy)	A - Award	D	8.22		26,880		26,880
2022-04-06	2022-04-04	4	Liu Hui	RLYB	Option (Right to Buy)	A - Award	D	8.22		26,880		26,880
2022-03-23	2022-03-21	4	Fryer Jeffrey M	RLYB	Common Stock	P - Purchase	I		8.0400	3,000	24		47,048
2022-02-10	2022-02-08	4	5AM Opportunities I, L.P.	RLYB	Common Stock	S - Sale	I		13.0500	-139,539	-1,821		2,645,087
2022-02-10	2022-02-08	4	5AM Opportunities I, L.P.	RLYB	Common Stock	S - Sale	I		13.0500	-70,461	-920		1,335,637
2022-02-10	2022-02-08	4	PARMAR KUSH 5AM Opportunities I, L.P.	RLYB	Common Stock	S - Sale	I		13.0500	-70,461	-920		1,335,637
2022-02-10	2022-02-08	4	PARMAR KUSH 5AM Ventures V, L.P.	RLYB	Common Stock	S - Sale	I		13.0500	-139,539	-1,821		2,645,087
2022-02-09	2022-02-07	4	Fryer Jeffrey M	RLYB	Option (Right to Buy)	A - Award	D	15.04		62,000		62,000
2022-02-09	2022-02-07	4	Uden Stephen	RLYB	Option (Right to Buy)	A - Award	D	15.04		62,000		62,000
2022-02-09	2022-02-07	4	MACKAY MARTIN	RLYB	Option (Right to Buy)	A - Award	D	15.04		62,000		62,000
2022-02-09	2022-02-07	4	Ryder Steven	RLYB	Option (Right to Buy)	A - Award	D	15.04		62,000		62,000
2022-01-21	2022-01-19	4	Fryer Jeffrey M	RLYB	Common Stock	P - Purchase	I		8.7000	1,400	12		44,048
2022-01-14	2022-01-13	4	Uden Stephen	RLYB	Common Stock	P - Purchase	D		9.6200	807	8		719,127
2022-01-14	2022-01-13	4	Uden Stephen	RLYB	Common Stock	P - Purchase	D		9.0600	4,193	38		718,320
2022-01-14	2022-01-12	4	Uden Stephen	RLYB	Common Stock	P - Purchase	D		10.5500	5,000	53		714,127
2022-01-14	2021-07-28	4	Uden Stephen	RLYB	Option (Right to Buy)	A - Award	D	13.00		160,000		160,000
2022-01-14	2021-07-28	4	Uden Stephen	RLYB	Series B Preferred Units	J - Other	D			-107,891		0
2022-01-14	2021-07-28	4	Uden Stephen	RLYB	Series A-2 Preferred Units	J - Other	D			-100,000		0
2022-01-14	2021-07-28	4	Uden Stephen	RLYB	Series A-1 Preferred Units	J - Other	D			-150,000		0
2022-01-14	2021-07-28	4	Uden Stephen	RLYB	Common Units	J - Other	D			-4,820,000		0
2022-01-14	2021-07-28	4	Uden Stephen	RLYB	Common Stock	J - Other	D			709,127			709,127
2022-01-12	2022-01-11	4	MACKAY MARTIN	RLYB	Common Stock	P - Purchase	D		10.6500	4,496	48		282,609
2022-01-12	2022-01-10	4	MACKAY MARTIN	RLYB	Common Stock	P - Purchase	D		10.1000	5,504	56		278,113
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Option (Right to Buy)	A - Award	D	13.00		160,000		160,000
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Series B Preferred Units	J - Other	I			-107,891		0
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Series A-2 Preferred Units	J - Other	I			-100,000		0
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Series A-1 Preferred Units	J - Other	I			-150,000		0
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Common Units	J - Other	I			-2,564,999		0
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Common Units	J - Other	D			-2,255,001		0
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Common Stock	J - Other	I			436,517			436,517
2022-01-12	2021-07-28	4	MACKAY MARTIN	RLYB	Common Stock	J - Other	D			272,609			272,609
2022-01-11	2022-01-07	4	Fryer Jeffrey M	RLYB	Common Stock	P - Purchase	I		9.4400	9,295	88		42,648
2022-01-11	2022-01-07	4	Fryer Jeffrey M	RLYB	Common Stock	P - Purchase	I		8.9700	705	6		33,353
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Option (Right to Buy)	A - Award	D	13.00		160,000		160,000
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Series B Preferred Units	J - Other	I			-107,891		0
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Series A-2 Preferred Units	J - Other	I			-100,000		0
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Series A-1 Preferred Units	J - Other	I			-75,000		0
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Series A-1 Preferred Units	J - Other	I			-75,000		0
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Common Units	J - Other	I			-1,282,500		0
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Common Units	J - Other	I			-1,282,500		0
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Common Units	J - Other	I			-2,255,000		0
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Common Stock	J - Other	I			201,934			201,934
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Common Stock	J - Other	I			201,934			201,934
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Common Stock	J - Other	I			272,609			272,609
2022-01-11	2021-07-28	4	Fryer Jeffrey M	RLYB	Common Stock	J - Other	I			32,648			32,648
2022-01-05	2022-01-03	4	Hopfner Robert Lorne	RLYB	Option (Right to Buy)	A - Award	D	10.38		6,242		6,242
2022-01-05	2022-01-03	4	HUNT RONALD	RLYB	Option (Right to Buy)	A - Award	D	10.38		6,242		6,242
2022-01-05	2022-01-03	4	PARMAR KUSH	RLYB	Option (Right to Buy)	A - Award	D	10.38		5,772		5,772
2022-01-05	2022-01-03	4	Soteropoulos Paula	RLYB	Option (Right to Buy)	A - Award	D	10.38		5,369		5,369
2022-01-05	2022-01-03	4	SHANNON TIMOTHY M	RLYB	Option (Right to Buy)	A - Award	D	10.38		6,041		6,041
2021-08-04	2021-08-02	4	PARMAR KUSH 5AM Opportunities I, L.P.	RLYB	Common Stock	P - Purchase	I		13.0000	615,384	8,000		1,406,098
2021-08-04	2021-07-28	4	PARMAR KUSH	RLYB	Option (Right to Buy)	A - Award	D	13.00		13,440		13,440
2021-08-04	2021-07-28	4	PARMAR KUSH 5AM Opportunities I, L.P.	RLYB	Series B Preferred Units	J - Other	I			-5,034,955		0
2021-08-04	2021-07-28	4	PARMAR KUSH 5AM Ventures V, LP.	RLYB	Series B Preferred Units	J - Other	I			-7,192,795		0
2021-08-04	2021-07-28	4	PARMAR KUSH 5AM Ventures V, LP.	RLYB	Series A-2 Preferred Units	J - Other	I			-8,742,654		0
2021-08-04	2021-07-28	4	PARMAR KUSH 5AM Ventures V, LP.	RLYB	Series A-1 Preferred Units	J - Other	I			-1,795,946		0
2021-08-04	2021-07-28	4	PARMAR KUSH 5AM Opportunities I, L.P.	RLYB	Common Stock	J - Other	I			790,714			790,714
2021-08-04	2021-07-28	4	PARMAR KUSH 5AM Ventures V, L.P.	RLYB	Common Stock	J - Other	I			2,784,626			2,784,626
2021-08-04		3/A	Schwab Andrew J. footnote	RLYB	Common Stock		I						790,714
2021-08-04		3/A	Schwab Andrew J. footnote	RLYB	Common Stock		I						2,784,626
2021-08-04	2021-08-02	4	5AM Opportunities I, L.P.	RLYB	Common Stock	P - Purchase	I		13.0000	615,384	8,000		1,406,098
2021-08-04	2021-08-02	4	Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P	RLYB	Common Stock	P - Purchase	I		13.0000	576,923	7,500		2,267,411
2021-08-04	2021-07-28	4	Hopfner Robert Lorne	RLYB	Option (Right to Buy)	A - Award	D	13.00		13,440		13,440
2021-08-04	2021-07-28	4	Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P.	RLYB	Series B Preferred Units	J - Other	I			-10,789,193		0
2021-08-04	2021-07-28	4	Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P	RLYB	Common Stock	J - Other	I			1,694,388			1,694,388
2021-08-04	2021-08-02	4	HUNT RONALD	RLYB	Common Stock	P - Purchase	I		13.0000	153,846	2,000		2,301,603
2021-08-04	2021-08-02	4	HUNT RONALD	RLYB	Common Stock	P - Purchase	I		13.0000	153,846	2,000		2,301,603
2021-08-04	2021-07-28	4	HUNT RONALD	RLYB	Option (Right to Buy)	A - Award	D	13.00		13,440		13,440
2021-08-04	2021-07-28	4	HUNT RONALD	RLYB	Series B Preferred Units	J - Other	I			-2,157,838		0
2021-08-04	2021-07-28	4	HUNT RONALD	RLYB	Series A-2 Preferred Units	J - Other	I			-8,742,654		0
2021-08-04	2021-07-28	4	HUNT RONALD	RLYB	Series A-1 Preferred Units	J - Other	I			-1,795,946		0
2021-08-04	2021-07-28	4	HUNT RONALD	RLYB	Common Stock	J - Other	I			1,993,911			1,993,911
2021-08-04	2021-08-02	4	SHANNON TIMOTHY M Canaan XI L.P.	RLYB	Common Stock	P - Purchase	I		13.0000	76,923	1,000		2,409,712
2021-08-04	2021-07-28	4	SHANNON TIMOTHY M	RLYB	Option (Right to Buy)	A - Award	D	13.00		13,440		13,440
2021-08-04	2021-07-28	4	SHANNON TIMOTHY M Canaan XI L.P.	RLYB	Series B Preferred Units	J - Other	I			-4,315,676		0
2021-08-04	2021-07-28	4	SHANNON TIMOTHY M Canaan XI L.P.	RLYB	Series A-2 Preferred Units	J - Other	I			-8,742,654		0
2021-08-04	2021-07-28	4	SHANNON TIMOTHY M Canaan XI L.P.	RLYB	Series A-1 Preferred Units	J - Other	I			-1,795,946		0
2021-08-04	2021-07-28	4	SHANNON TIMOTHY M Canaan XI L.P.	RLYB	Common Stock	J - Other	I			2,332,789			2,332,789
2021-08-04	2021-08-02	4	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	RLYB	Series B Preferred Units	C - Conversion	I			-10,789,193		0
2021-08-04	2021-08-02	4	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	RLYB	Common Stock	C - Conversion	I			1,694,388			1,694,388
2021-08-02	2021-07-29	4	VIKING GLOBAL INVESTORS LP See Explanation of Responses	RLYB	Series B Preferred Units	C - Conversion	I			-21,578,387		0
2021-08-02	2021-07-29	4	VIKING GLOBAL INVESTORS LP See Explanation Responses	RLYB	Common Stock	P - Purchase	I		13.0000	806,000	10,478		4,194,777
2021-08-02	2021-07-29	4	VIKING GLOBAL INVESTORS LP See Explanation Responses	RLYB	Common Stock	C - Conversion	I			3,388,777			3,388,777
2021-07-29		3	Schwab Andrew J. footnote	RLYB	Common Stock		I						2,778,216
2021-07-29		3	Schwab Andrew J. footnote	RLYB	Common Stock		I						788,894
2021-07-29		3	PARMAR KUSH	RLYB	Common Stock		I						790,714
2021-07-29		3	PARMAR KUSH	RLYB	Common Stock		I						2,784,626
2021-07-29		3	Iancovici Lucian	RLYB	No securities beneficially owned		D						0
2021-07-29		3	Soteropoulos Paula	RLYB	Common Stock		D						23,882
2021-07-29		3	Boudreau Helen M	RLYB	Common Stock		D						23,882
2021-07-29		3	SHANNON TIMOTHY M Canaan XI L.P.	RLYB	Common Stock		I						2,332,789
2021-07-29		3	Ryder Steven	RLYB	Common Stock		D						192,370
2021-07-29		3	HUNT RONALD New Leaf Ventures III, L.P.	RLYB	Common Stock		I						1,993,911
2021-07-29		3	Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P.	RLYB	Common Stock		I						1,694,388
2021-07-29		3	MACKAY MARTIN	RLYB	Common Stock		I						436,517
2021-07-29		3	MACKAY MARTIN	RLYB	Common Stock		D						272,609
2021-07-29		3	Uden Stephen	RLYB	Common Stock		D						709,127
2021-07-29		3	Fryer Jeffrey M	RLYB	Common Stock		I						32,648
2021-07-29		3	Fryer Jeffrey M	RLYB	Common Stock		I						201,934
2021-07-29		3	Fryer Jeffrey M	RLYB	Common Stock		I						272,609
2021-07-29		3	Fryer Jeffrey M	RLYB	Common Stock		I						201,934

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）

RLYB / Rallybio Corporation - Insider Trading and Ownership Report - SEC Form 3, 4, 5